FDA Investigator Patsy J Domingo

Patsy J Domingo has inspections in 11 countries as of 03 Nov 2023. Patsy J Domingo has collaborated with a combinined 7290 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
140
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland, United States of America, Germany, France, Hungary, Belgium, Canada, Austria, Romania, Ireland
Co-Investigator(s):
Adam J Wilson, Addam S Reynolds, Adetutu M Gidado, Alan M Barker, Alan M Roberts, Alan P Kurtzberg, Alanna Lmussawwir Bias, Albinus D'sa, PhD, Alice S Tsao, Amanda L Baskin, Amanda M Dunneback, Amy S Graf, Andrace Lde Yampert, Andrea D Swingle, Andrea F White, Anh M Lac, Anita Narula, PhD, Ann Marie Montemurro, Ann Marie Schofield, Ann Raju Daniel, Anthony F Lorenzo, Anthony R Petriella, Arsen Karapetyan, Art O Czabaniuk, Aurora Miha Trifanov, Ava M Bowman, Azza Talaat, Barbara A Rusin, Barbara Janine Breithaupt, Bei Y He, Benjamin J Smith, Bo Chi, PhD, Bonita S Chester, Brandy N Lepage, Brent M Dehaan, Brentley S Collins, Brian M Campbell, Brian P Putz, Brittany D Terhar, Bruce D Meade, Bruce H Mccullough, Burnell M Henry, Byungja E Marciante, Carl A Huffman, III, Carla J Lundi, Carmen M Faraianu, Caroline H Le, Caroline Strasinger, Carolyn J Oyster, Catherine V Quinlan, Cathie S Marshall, CDR Donald Ertel, CDR Ileana Barreto Pettit, Charisse K Green, Charles I Ann, Charles L Zhou, Charles M Spyr, Charles R Cote, RIC, Cheng H Yen, Cheryl A Clausen, Cheryl A Fuhs, Cheryl Llove Harris, Cheryl M Monroe, Christian D Lynch (CDL), Christine A Harman, PhD, Constantin Y Philopoulos, Corrine M Carter, Courtney E Hillier, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia L Aycock, Cynthia L Kelley, Cynthia Li, Danial S Hutchison, Daniel J Brown, Daniel J Grabicki, Daniel L Obrzut, Darren S Morgan, David A Paterson, David E Bailey, David G Eng, David J Gasparovich, David Perkins, Dawn C Olenjack, Deanna L Lampley, Deanne Lampley, Debara R Reese, Debara Reese, Deborah M Trout, Denise L Burosh, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Dennis E Swartz, Devon Jenkins, Dina A Tallman, Don H Bark, PhD, Donald C Obenhuber, PhD, Donna Mwilliams Hill, Douglas A Campbell, Eboni S Funderbunc, Eboni S Funderburk, Edmund F Mrak, Jr, Eliezar Ramos, Elizabeth M Kelley, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Enrico Joset Mangahis, Ephrem Hunde, PhD, Eric S Pittman, Erica N Koory, Erika V Butler, Erin D Mccaffery, Felix Maldonado, Frederick Razzaghi, French, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Geneve Maxwell, Geraldine D Sanders, Gwyn G Dickinson, Hamet M Toure, PharmD MPH, Hans T Meyers, Hartman, Helen B Ricalde, Holly Brevig, Ifueko Osemwota, Ivy E Sweeney, Jacek Cieslak, PhD, Jacob G Lutz, Jacqueline Mdiaz Albertini, James C Maclaughlin, James D Bridges, James E Szelc, James I Giefer, James K Ireland, James L Dunnie, Jr, James P Mcevoy, James R Evans, Janet L Bowen, Jawaid Hamid, Jean Blackston Hill, Jean Blackstone Hill, Jean Lhu Primmer, Jean Salemme, PhD, Jeffrey A Sommers, Jeffrey B Medwid, PhD, Jeffrey D Meng, Jeffrey O Hilgendorf, Jennifer A Kemp, Jennifer L Bridgewater, Jennifer L Schmidt, Jeremy W Rotton, Joan Johnson, Joanne E King, John P Mistler, Jonathan R Loving, Joohi Castelvetere, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose Martinez, Jr, Jose R Hernandez, Joseph A Piechocki, Joseph R Strelnik, Joseph T Madak, Judith A Jankowski, Julie D Bringger, Justine Tomasso, Kalavati Suvarna, PhD, Karen E D'orazio, Karen M Montgomery (KMM), Karen Takahashi, Katherine Szestypalow, Kathleen D Culver, Kathryn A Guardiola, Kathryn E Ogger, Kathryn G Brown, Keith A Schwartz, Kelley L Clark, Kenneth H Williams, Kent C Faul, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kham Phommachanh, Kip J Hanks, Kristin M Abaonza, Kristina L Conroy, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Lauren E Sexton, Lauren Iacono Connors, PhD, Lauren L Vajo, Lauren M Lilly, PhD, Laurie A Haxel, Lawrence Harmon, Jr, Lawrence J Stringer, LCDR Anastasia Mpiliafas Brown, LCDR Debra Emerson, LCDR Michael H Tollon, Leigh Anne Myers, Leroy Terrelonge, Leslie A Paul, Liatte Kreuger, PharmD, Linda Thai, Lindsey Brown, PhD, Lisa J Joseph, Lisa M Bellows, Lisa P Oakes, Lisa Pierce Oakes, Logan T Williams, Luella J Rossi, Luis A Dasta, Madushini Dharmasena, PhD, Mamta Gautam Basak, PhD, Margaret M Annes, Maria Estrella, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Marsha W Major, Martha Sullivan Mynck, Martha Sullivan Myrick, Martin R Vowell, Matthew B Casale, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melina Rodriguez Upton, Mercy Oyugi, Miah I Schneider, Michael A Taylor, Michael E Maselli, Michael L Casner, Michael P Sheehan, Michael R Goga, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Miguel A Martinez, Miguel A Mortimer, Mihaly S Ligmond, Montgomery Montgomery, Karen M, Mra B Kamberem, Mra Davism, Mra Mcculloughj, Mra Munizn, Muna Algharibeh, Myra K Casey, Nadeem I Chaudhry, Nailing Zhang, Nancy A Bellamy, Nancy F Scheraga, Nancy G Schmidt, Nancy N Bellamy, Natalie A Mickelsen, DVM, Neal D Singletary, PhD, Neali H Lucas, Nicholas A Violand, Nicholas E Boyd, Nicholas J Presto, Nicholas L Paulin, Omotunde O Osunsanmi, Owens, Paige E Shelborne, Paranthaman Senthamaraikannan, Parul M Patel, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patrick L Wisor, Patsy I Domingo, Paul A Bonneau, Paul L Bellamy, Paul L Figarole, Jr, Paula A Trost, Peng Zhou, Philip A Klimkewicz, Prabhu P Raju, Qiao Y Bobo, Qin Xu, Rabin N Ghoshal, Rachel C Harrington, Rafeeq A Habeeb, Ralph A Erickson, Ralph H Vocque, Raquel Gonzalez Rivera, Raymond R Roy, PhD, Raymond T Oji, Rebecca E Dombrowski, Rebecca K Olin, Rebecca Rodriguez, Regina T Brown, Reginald Walker, Renee L Rice, PhD, Reyes Candau Chacon, PhD, Richard W Thornton, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert J Ham, Robert J Martin, Robert L Lewis, Jr, Robert M Barbosa, Robert R Barbosa, Rochelle L Cross, Roger A Hartman, Roger F Zabinski, Rohn R Robertson, Ronald G Crawford, Ronald J Kozara, Rose M Ashley, Russell J Glapion, Russell K Riley, Ryan J Benedict, Salwa K Poole, Samantha J Bradley, Sandra A Boyd, Sandra A Hughes, Sangeeta M Khurana, PhD, Sanket N Patel, Santos E Camara, Sarah B Tanksley, Sarah E Mcmullen, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sargum C Sood, Schwierjohann Schwierjohann, Lindsey, Scott A Golladay, Scott T Ballard, Sean R Bryd, Seifert Seifert, Wayne E, Sena G Dissmeyer, Sharon K Thoma, PharmD, Shelby N Turner, Sherri J Jackson, Shirley J Berryman, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, Sixto M Mercado, Sixto M Mercado Rios, Sneha S Patel, State Agency, Stephanie A Slater, MS, Stephen D Eich, Stephen J Koniers, Steven C Derrick, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susanna E Ford, Analyst, Susant Hadman, Suyang Qin, Tara R Gooen, Terri L Dodds, Theodore N Sietsema, Thomas A Peter, Thomas J Arista, Thomas J Cosgrove, Thuy T Nguyen, LCDR, Tina M Pawlowski, Tina S Roecklein, Tonnie L Carter, Torrance J Slayton, Tracey Asinjen Wiersma, Tracey L Harris, Tracey L Siebesma, Tracey L Taylor, Twana R Chandler, Uduak M Inokon, Virgilio F Pacio, CSO, Vlada Matusovsky, Wayne E Seifert, William A Warnick, William C Gilbert, William D Tingley, William J Leonard, William R Brubaker, Xianghong Jing (Emily), PhD, Xiaokuang Lai, PhD, Yangmin Ning, Yasamin Ameri, Yumi J Hiramine, Yvesna C Blaise, Yvonne E Lozano, Zabinski Zabinski, Roger F, Zhihao Qiu (Peter), PhD

Patsy J Domingo's Documents

Publish Date Document Type Title
March, 2001 EIR Pharmacia & Upjohn Company LLC - EIR, 2001-03-07
September, 2002 FDA 483 Wayne Concept Manufacturing Co Inc - Form 483, 2002-09-10
December, 2000 FDA 483 Ash Stevens LLC - Form 483, 2000-12-21
December, 2001 FDA 483 Emergent Biodefense Operations Lansing LLC - Form 483, 2001-12-19
December, 2001 FDA 483 Par Sterile Products LLC - Form 483, 2001-12-07
March, 2002 EIR Pharmacia & Upjohn Company LLC - EIR, 2002-03-14
March, 2003 EIR Par Sterile Products LLC - EIR, 2003-03-03
June, 2004 EIR Lannett Company, Inc. - EIR, 2004-06-04
August, 2000 EIR Contract Pharmaceuticals Limited Canada - EIR, 2000-08-11
September, 2004 EIR L. Perrigo Company - EIR, 2004-09-08
October, 2006 EIR King Pharmaceuticals LLC - EIR, 2006-10-26
March, 2011 FDA 483 L. Perrigo Company - Form 483, 2011-03-21
April, 2001 FDA 483 Response Sun Pharmaceutical Industries, Inc. - Form 483R, 2001-05-25
June, 2011 EIR Nutrition & Biosciences USA 1, LLC - EIR, 2011-06-16
September, 2000 FDA 483 Response Nutrition & Biosciences USA 1, LLC - Form 483R, 2000-10-12
August, 2005 EIR L. Perrigo Company - EIR, 2005-08-10
December, 2006 FDA 483 L. Perrigo Company - Form 483, 2006-12-15
April, 2002 EIR Siegfried PharmaChemikalien Minden Gmbh - EIR, 2002-04-24
August, 2005 FDA 483 L. Perrigo Company - Form 483, 2005-08-10
September, 2001 FDA 483 Abbott Laboratories - Form 483, 2001-09-28
May, 2001 FDA 483 Takeda Ireland Limited - Form 483, 2001-05-17
September, 2010 FDA 483 Baxter Pharmaceutical Solutions LLC - Form 483, 2010-09-23
May, 2001 FDA 483 GlaxoSmithKline - Form 483, 2001-05-24
September, 2004 FDA 483 L. Perrigo Company - Form 483, 2004-09-08
January, 2010 FDA 483 L. Perrigo Company - Form 483, 2010-01-14
May, 2005 FDA 483 Eli Lilly and Company - Form 483, 2005-05-19
January, 2003 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2003-01-30
September, 2002 FDA 483 Wayne Chemical Inc. - Form 483, 2002-09-10
May, 2003 FDA 483 Response Central Admixture Pharmacy Services, Inc. - Form 483R, 2003-05-23
May, 2001 EIR GlaxoSmithKline - EIR, 2001-06-29
September, 2003 FDA 483 Response Nutrition & Biosciences USA 1, LLC - Form 483R, 2003-10-10
September, 2007 FDA 483 L. Perrigo Company - Form 483, 2007-09-13
June, 2008 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2008-06-11
September, 2002 FDA 483 Vintage Chemical Inc - Form 483, 2002-09-11
December, 2006 FDA 483 Response L. Perrigo Company - Form 483R, 2007-01-09
September, 2003 FDA 483 Nutrition & Biosciences USA 1, LLC - Form 483, 2003-09-19
March, 2003 FDA 483 Response UCB Pharma S.A. - Form 483R, 2003-04-28
June, 2002 FDA 483 Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC - Form 483, 2002-06-18
March, 2000 EIR Sun Pharmaceutical Industries, Inc. - EIR, 2000-03-10
July, 2009 FDA 483 DDP Specialty Electronic Materials US 9, LLC - Form 483, 2009-07-08
March, 2001 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2001-03-07
February, 2001 FDA 483 Response Par Sterile Products LLC - Form 483R, 2001-03-30
June, 2000 FDA 483 Morton International, Inc dba Morton Salt, Inc.. - Form 483, 2000-06-15
September, 2007 EIR L. Perrigo Company - EIR, 2007-09-13
May, 2003 EIR Central Admixture Pharmacy Services, Inc. - EIR, 2003-05-23
September, 2005 EIR Tower Laboratories Ltd - EIR, 2005-09-28
April, 2002 FDA 483 Response Siegfried PharmaChemikalien Minden Gmbh - Form 483R, 2002-05-28
July, 2000 EIR Par Sterile Products LLC - EIR, 2000-07-28
August, 2000 FDA 483 Response Contract Pharmaceuticals Ltd. - Form 483R, 2000-08-11
January, 2008 FDA 483 Eli Lilly and Company - Form 483, 2008-01-31
August, 2005 FDA 483 Response L. Perrigo Company - Form 483R, 2005-09-15
March, 2006 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2006-03-21
May, 2009 FDA 483 Response Sun Pharmaceutical Industries, Inc. - Form 483R, 2009-06-19
November, 2008 FDA 483 L. Perrigo Company - Form 483, 2008-11-07
January, 2003 EIR Pharmacia & Upjohn Company LLC - EIR, 2003-01-30
February, 2005 FDA 483 Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC - Form 483, 2005-02-14
December, 2004 EIR Par Sterile Products LLC - EIR, 2004-12-06
May, 2010 FDA 483 Tower Laboratories Ltd - Form 483, 2010-05-12
December, 2001 EIR Emergent Biodefense Operations Lansing LLC - EIR, 2001-12-19
April, 2010 FDA 483 DSC Laboratories, LLC - Form 483, 2010-04-13
June, 2006 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2006-06-21
September, 2003 EIR Nutrition & Biosciences USA 1, LLC - EIR, 2003-09-19
December, 2008 FDA 483 Caraco Pharmaceutical Laboratories, LTD. - Form 483, 2008-12-22
February, 2006 EIR Par Sterile Products LLC - EIR, 2006-02-08
September, 2001 FDA 483 Response Abbott Laboratories - Form 483R, 2001-09-28
October, 2002 FDA 483 U of M Nuclear Pharmacy - Form 483, 2002-10-18
May, 2001 EIR Takeda Ireland Limited - EIR, 2001-06-14
March, 2008 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2008-03-06
May, 2001 FDA 483 Response GlaxoSmithKline - Form 483R, 2001-06-21
August, 2001 FDA 483 Acura Pharmaceuticals, Inc. - Form 483, 2001-08-03
September, 2005 FDA 483 Response Tower Laboratories Ltd - Form 483R, 2005-11-02
August, 2010 FDA 483 Aurorium LLC - Form 483, 2010-08-27
February, 2001 EIR Par Sterile Products LLC - EIR, 2001-02-15
September, 2000 FDA 483 Nutrition & Biosciences USA 1, LLC - Form 483, 2000-09-29
January, 2004 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2004-01-30
May, 2005 FDA 483 Response Eli Lilly and Company - Form 483R, 2005-05-19
March, 2003 EIR UCB Pharma S.A. - EIR, 2003-03-28
April, 2001 EIR Sun Pharmaceutical Industries, Inc. - EIR, 2001-04-25
August, 2002 FDA 483 Baxter Pharmaceutical Solutions LLC - Form 483, 2002-08-08
June, 2004 FDA 483 Lannett Company, Inc. - Form 483, 2004-06-04
December, 2006 EIR L. Perrigo Company - EIR, 2006-12-15
June, 2003 FDA 483 Acura Pharmaceuticals, Inc. - Form 483, 2003-06-19
March, 2010 FDA 483 Future Pak LLC - Form 483, 2010-03-10
August, 2000 FDA 483 Contract Pharmaceuticals Ltd. - Form 483, 2000-08-11
November, 2011 FDA 483 Corium Innovations, Inc. - Form 483, 2011-11-07
May, 2009 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2009-05-12
November, 2008 EIR L. Perrigo Company - EIR, 2008-11-07
March, 2001 FDA 483 Response Pharmacia & Upjohn Company LLC - Form 483R, 2001-03-21
December, 2011 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2011-12-13
September, 2004 FDA 483 Response L. Perrigo Company - Form 483R, 2004-09-21
April, 2001 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2001-04-25
April, 2009 EIR Caraco Pharmaceutical Laboratories, LTD. - EIR, 2009-04-09
August, 2000 EIR Contract Pharmaceuticals Ltd. - EIR, 2000-08-11
March, 2004 FDA 483 Tykel Distributors - Form 483, 2004-03-03
September, 2010 FDA 483 Eli Lilly and Company - Form 483, 2010-09-03
March, 2000 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2000-03-10
July, 2000 FDA 483 Par Sterile Products LLC - Form 483, 2000-07-28
April, 2002 FDA 483 Siegfried PharmaChemikalien Minden Gmbh - Form 483, 2002-04-24
January, 2003 FDA 483 Response Pharmacia & Upjohn Company LLC - Form 483R, 2003-02-25
June, 2004 FDA 483 Response Lannett Company, Inc. - Form 483R, 2004-06-15
September, 2000 EIR Nutrition & Biosciences USA 1, LLC - EIR, 2000-09-29
June, 2011 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2011-06-28
September, 2006 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2006-09-29
September, 2002 FDA 483 Oza Compound Products, LLC - Form 483, 2002-09-11
November, 2008 FDA 483 Response L. Perrigo Company - Form 483R, 2008-12-04
June, 2010 FDA 483 Vortech Pharmaceuticals, Ltd. - Form 483, 2010-06-28
June, 2008 FDA 483 Response Sun Pharmaceutical Industries, Inc. - Form 483R, 2008-07-10
November, 2007 FDA 483 Cayman Chemical Company, Inc. - Form 483, 2007-11-13
December, 2003 EIR Eli Lilly and Company - EIR, 2003-12-05
February, 2001 FDA 483 Par Sterile Products LLC - Form 483, 2001-02-15
June, 2002 EIR Ash Stevens LLC - EIR, 2002-06-03
May, 2003 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2003-05-23
December, 2004 FDA 483 Par Sterile Products LLC - Form 483, 2004-12-06
March, 2003 FDA 483 Par Sterile Products LLC - Form 483, 2003-03-03
December, 2008 FDA 483 Response Caraco Pharmaceutical Laboratories, LTD. - Form 483R, 2009-01-21
March, 2003 FDA 483 UCB Pharma S.A. - Form 483, 2003-03-28
September, 2001 EIR Abbott Laboratories - EIR, 2001-09-28
October, 2001 FDA 483 Cayman Chemical Company, Inc. - Form 483, 2001-10-25
July, 2003 EIR Pharmacia & Upjohn Company LLC - EIR, 2003-07-18
March, 2003 EIR Pfizer Inc. - EIR, 2003-03-17
December, 2008 FDA 483 Caraco Pharmaceutical Laboratories, LTD. - Form 483, 2008-12-22
May, 2001 FDA 483 Response Takeda Ireland Limited - Form 483R, 2001-06-13
February, 2002 FDA 483 Baxter COMPASS - Form 483, 2002-02-07
May, 2005 EIR Eli Lilly and Company - EIR, 2005-05-19

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more